{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:01:50Z","timestamp":1789912910173,"version":"4.0.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,20]]},"DOI":"10.7759\/cureus.116589","type":"journal-article","created":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T13:30:12Z","timestamp":1789911012000},"source":"Crossref","is-referenced-by-count":0,"title":["A Retrospective Analysis of Lifestyle Factors, Prokinetic Use, and Clinical Outcomes in Patients With Gastroparesis and Comorbid Hepatic Fibrosis at King Hussein Medical Center"],"prefix":"10.7759","author":[{"given":"Laith","family":"AL Adaileh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laith","family":"Toeimeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majd","family":"Al Sarhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kafa","family":"Dalal'ah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwan","family":"Alzayadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Bani Salama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rou'a","family":"Al Adaileh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aseel","family":"Alhusban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-018-0038-z","article-title":"Gastroparesis","volume":"4","author":"Camilleri M","year":"2018","unstructured":"Camilleri M, Chedid V, Ford AC, et al.. Gastroparesis. Nat Rev Dis Primers. 2018, 4:41. 10.1038\/s41572-018-0038-z","journal-title":"Nat Rev Dis Primers"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.09.055","article-title":"American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis","volume":"127","author":"Parkman HP","year":"2004","unstructured":"Parkman HP, Hasler WL, Fisher RS. American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology. 2004, 127:1592-622. 10.1053\/j.gastro.2004.09.055","journal-title":"Gastroenterology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-318712","article-title":"Gastroparesis: a turning point in understanding and treatment","volume":"68","author":"Grover M","year":"2019","unstructured":"Grover M, Farrugia G, Stanghellini V. Gastroparesis: a turning point in understanding and treatment. Gut. 2019, 68:2238-50. 10.1136\/gutjnl-2019-318712","journal-title":"Gut"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease\u2014meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi ZM","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease\u2014meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016, 64:73-84. 10.1002\/hep.28431","journal-title":"Hepatology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"149","author":"Angulo P","year":"2015","unstructured":"Angulo P, Kleiner DE, Dam-Larsen S, et al.. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology. 2015, 149:389-97.e10. 10.1053\/j.gastro.2015.04.043","journal-title":"Gastroenterology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis","volume":"65","author":"Dulai PS","year":"2017","unstructured":"Dulai PS, Singh S, Patel J, et al.. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis. Hepatology. 2017, 65:1557-65. 10.1002\/hep.29085","journal-title":"Hepatology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2022.01.058","article-title":"Nonalcoholic fatty liver disease and the gut-liver axis: exploring an undernutrition perspective","volume":"162","author":"Bauer KC","year":"2022","unstructured":"Bauer KC, Littlejohn PT, Ayala V, Creus-Cuadros A, Finlay BB. Nonalcoholic fatty liver disease and the gut-liver axis: exploring an undernutrition perspective. Gastroenterology. 2022, 162:1858-75.e2. 10.1053\/j.gastro.2022.01.058","journal-title":"Gastroenterology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.gtc.2014.11.005","article-title":"Diabetic gastroparesis","volume":"44","author":"Koch KL","year":"2015","unstructured":"Koch KL, Calles-Escand\u00f3n J. Diabetic gastroparesis. Gastroenterol Clin North Am. 2015, 44:39-57. 10.1016\/j.gtc.2014.11.005","journal-title":"Gastroenterol Clin North Am"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-018-0454-9","article-title":"Diabetic gastroparesis: principles and current trends in management","volume":"9","author":"Krishnasamy S","year":"2018","unstructured":"Krishnasamy S, Abell TL. Diabetic gastroparesis: principles and current trends in management. Diabetes Ther. 2018, 9:1-42. 10.1007\/s13300-018-0454-9","journal-title":"Diabetes Ther"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.10.015","article-title":"Clinical features of idiopathic gastroparesis vary with sex, body mass, symptom onset, delay in gastric emptying, and gastroparesis severity","volume":"140","author":"Parkman HP","year":"2011","unstructured":"Parkman HP, Yates K, Hasler WL, et al.. Clinical features of idiopathic gastroparesis vary with sex, body mass, symptom onset, delay in gastric emptying, and gastroparesis severity. Gastroenterology. 2011, 140:101-15. 10.1053\/j.gastro.2010.10.015","journal-title":"Gastroenterology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v23.i24.4428","article-title":"Healthcare utilization and costs associated with gastroparesis","volume":"23","author":"Wadhwa V","year":"2017","unstructured":"Wadhwa V, Mehta D, Jobanputra Y, Lopez R, Thota PN, Sanaka MR. Healthcare utilization and costs associated with gastroparesis. World J Gastroenterol. 2017, 23:4428-36. 10.3748\/wjg.v23.i24.4428","journal-title":"World J Gastroenterol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.11.013","article-title":"Non-invasive assessment of non-alcoholic fatty liver disease: clinical prediction rules and blood-based biomarkers","volume":"68","author":"Vilar-Gomez E","year":"2018","unstructured":"Vilar-Gomez E, Chalasani N. Non-invasive assessment of non-alcoholic fatty liver disease: clinical prediction rules and blood-based biomarkers. J Hepatol. 2018, 68:305-15. 10.1016\/j.jhep.2017.11.013","journal-title":"J Hepatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis","volume":"52","author":"Tilg H","year":"2010","unstructured":"Tilg H, Moschen AR. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology. 2010, 52:1836-46. 10.1002\/hep.24001","journal-title":"Hepatology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2014.07.014","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration","volume":"12","author":"Vandenbroucke JP","year":"2014","unstructured":"Vandenbroucke JP, von Elm E, Altman DG, et al.. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Int J Surg. 2014, 12:1500-24. 10.1016\/j.ijsu.2014.07.014","journal-title":"Int J Surg"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling RK","year":"2006","unstructured":"Sterling RK, Lissen E, Clumeck N, et al.. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology. 2006, 43:1317-25. 10.1002\/hep.21178","journal-title":"Hepatology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo P","year":"2007","unstructured":"Angulo P, Hui JM, Marchesini G, et al.. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology. 2007, 45:846-54. 10.1002\/hep.21496","journal-title":"Hepatology"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.00456.x","article-title":"A double-blind multicenter comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesis","volume":"94","author":"Patterson D","year":"1999","unstructured":"Patterson D, Abell T, Rothstein R, Koch K, Barnett J. A double-blind multicenter comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesis. Am J Gastroenterol. 1999, 94:1230-4. 10.1111\/j.1572-0241.1999.00456.x","journal-title":"Am J Gastroenterol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1023\/B:QURE.0000021689.86296.e4","article-title":"Gastroparesis Cardinal Symptom Index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms","volume":"13","author":"Revicki DA","year":"2004","unstructured":"Revicki DA, Rentz AM, Dubois D, Kahrilas P, Stanghellini V, Talley NJ, Tack J. Gastroparesis Cardinal Symptom Index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms. Qual Life Res. 2004, 13:833-44. 10.1023\/B:QURE.0000021689.86296.e4","journal-title":"Qual Life Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.14960","article-title":"The American Neurogastroenterology and Motility Society Gastroparesis Cardinal Symptom Index-Daily Diary (ANMS GCSI-DD): psychometric validation and meaningful change threshold in patients with idiopathic or diabetic gastroparesis","volume":"37","author":"Chen YJ","year":"2025","unstructured":"Chen YJ, Coyne KS, Rodriguez D, et al.. The American Neurogastroenterology and Motility Society Gastroparesis Cardinal Symptom Index-Daily Diary (ANMS GCSI-DD): psychometric validation and meaningful change threshold in patients with idiopathic or diabetic gastroparesis. Neurogastroenterol Motil. 2025, 37:e14960. 10.1111\/nmo.14960","journal-title":"Neurogastroenterol Motil"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2012.01879.x","article-title":"Evaluating symptom outcomes in gastroparesis clinical trials: validity and responsiveness of the Gastroparesis Cardinal Symptom Index-Daily Diary (GCSI-DD)","volume":"24","author":"Revicki DA","year":"2012","unstructured":"Revicki DA, Camilleri M, Kuo B, Szarka LA, McCormack J, Parkman HP. Evaluating symptom outcomes in gastroparesis clinical trials: validity and responsiveness of the Gastroparesis Cardinal Symptom Index-Daily Diary (GCSI-DD). Neurogastroenterol Motil. 2012, 24:456-63. 10.1111\/j.1365-2982.2012.01879.x","journal-title":"Neurogastroenterol Motil"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-009-0717-4","article-title":"Gastroparesis and gastroparesis-like syndrome: response to therapy and its predictors","volume":"54","author":"Anaparthy R","year":"2009","unstructured":"Anaparthy R, Pehlivanov N, Grady J, Yimei H, Pasricha PJ. Gastroparesis and gastroparesis-like syndrome: response to therapy and its predictors. Dig Dis Sci. 2009, 54:1003-10. 10.1007\/s10620-009-0717-4","journal-title":"Dig Dis Sci"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.gtc.2014.11.007","article-title":"Nutritional considerations in the patient with gastroparesis","volume":"44","author":"Parrish CR","year":"2015","unstructured":"Parrish CR. Nutritional considerations in the patient with gastroparesis. Gastroenterol Clin North Am. 2015, 44:83-95. 10.1016\/j.gtc.2014.11.007","journal-title":"Gastroenterol Clin North Am"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/533209-a-retrospective-analysis-of-lifestyle-factors-prokinetic-use-and-clinical-outcomes-in-patients-with-gastroparesis-and-comorbid-hepatic-fibrosis-at-king-hussein-medical-center","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T13:30:13Z","timestamp":1789911013000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/533209-a-retrospective-analysis-of-lifestyle-factors-prokinetic-use-and-clinical-outcomes-in-patients-with-gastroparesis-and-comorbid-hepatic-fibrosis-at-king-hussein-medical-center"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,20]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.116589","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,20]]}}}